Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

235
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
99.4(c) 98.3(c) 96.75(c) 95.8(c) 96.2(c) Last
4 536 998 4 941 669 5 451 964 5 710 925 4 431 961 Volume
-0.30% -1.11% -1.58% -0.98% +0.42% Change
More quotes
Financials ($)
Sales 2015 53 342 M
EBIT 2015 13 799 M
Net income 2015 11 064 M
Debt 2015 6 443 M
Yield 2015 2,82%
Sales 2016 54 617 M
EBIT 2016 14 212 M
Net income 2016 11 229 M
Debt 2016 3 490 M
Yield 2016 3,01%
PER 2015 21,95
PER 2016 21,96
EV / Sales 2015 5,19x
EV / Sales 2016 5,02x
Capitalization 270 423 M
More Financials
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
04/23Earnings Release
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVARTIS AG
03/27 NOVARTIS : Alcon Research Assigned Patent
03/27 Ablynx announces extension of ion channel research collaboration with merck &..
03/26 NOVARTIS : BUSINESS INSIDE CHRONICLE BATH Family's greatest hope yet in the figh..
03/26 BIOLINERX : Posts Year End 2014 Financial Results
03/26 INCYTE : Jakavi (ruxolitinib) Gets European Commission Approval as First Targete..
03/25 NOVARTIS : Patent Issued for Combination Therapy
03/25 NOVARTIS : presented results of two new studies at AAD: CLEAR study showed Cosen..
03/25 NOVARTIS : Semma Therapeutics Enters into Agreement with Novartis
More news
Sector news : Pharmaceuticals - NEC
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 VALEANT PHARMACEUTICALS INTL : S&P Dow Jones Indices Announces Changes to the S&..
03/27DJGilead Sciences CEO's Pay Rose 23% Last Year
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/24 JUNO : Trying To Justify A $5.5B Valuation For A Year-Old Company
03/23 2015 could be the year of the blockbuster drug
03/20 Novartis' Cosentyx tops Janssen's Stelara on mutiple endpoints in Phase 3 stu..
03/20 Court rejects Amgen's bid to block Neupogen biosimilar
03/20 How ARM's Edward Lanphier Is Fighting For Cell Therapy Cures That Save Patien..


Comments 
Advertisement
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF